BioSpace News Archive

BioSpace Global Roundup, Jan. 2

Companies from across the globe announce updates to their business and pipeline.

December 31, 2019
·
3 min read
·
Alex Keown
Business

PharmaLink Announces Facility Expansion to Accommodate Growth

PharmaLink, Inc., an industry-leading pharmaceutical reverse distribution company, is announcing a series of initiatives designed to accommodate the changing dynamics of its business and the industry.

December 31, 2019
·
2 min read
Business

Parnell Pharmaceuticals Holdings Ltd Announces Business Update

Parnell announces 2019 year-to-date revenue growth of 9% over the first 9 months of 2018, start of work on its new 2019 CMO contract, and updates to 2019 financial results.

December 31, 2019
·
12 min read
Drug Development

Wave Life Sciences Shares Plunge After Mixed Results from Huntington’s Trial

Although the reduction in mHTT with the drug compared to placebo was statistically significant, there was no change in total huntingtin protein (tHTT) compared to placebo.

December 31, 2019
·
3 min read
·
Mark Terry
Business

Acceleron and Fulcrum Strike Deal to Address Pulmonary Diseases

On Monday, the two companies forged a collaboration and license agreement that has the potential to be worth more than $450 million.

December 31, 2019
·
3 min read
·
Alex Keown
New Insight into Colorectal Cancer Could Lead to New Therapies

Researchers at the University of Toronto have identified a protein called Importin-11 that transports beta-catenin into the nucleus of colon cancer cells, where it drives cell proliferation.

December 31, 2019
·
2 min read
·
Mark Terry
With Scrutiny of Insulin Drugmakers, Is Novo Nordisk a Buy for 2020 Investors?

With a new year upon us, some analysts are already picking potential winners in the market for 2020. One of those companies could be Denmark-based Novo Nordisk.

December 31, 2019
·
2 min read
·
Alex Keown
Deals

Short of Funding, NPXe Files for Bankruptcy and Seeks to Sell Assets

The decision to file Chapter 11 followed a close examination of the company’s strategic options and current financing.

December 31, 2019
·
2 min read
·
Alex Keown
Policy

SciTech Development, LLC Announces FDA Acceptance of Investigational New Drug (IND) Application for ST-001 nanoFenretinide in Patients with T-Cell Lymphoma

Company will present at Biotech Showcase™ 2020 on Monday, 01/13/20 at 11:15am PST in San Francisco, CA

December 31, 2019
·
4 min read
BioMidwest

Polarean Imaging - New System Delivery and Installation

Polarean Imaging plc announces that the Company has delivered and installed its latest research unit order for a 9820 Xenon Polariser system from the University of Iowa Hospitals and Clinics (“UI Hospitals & Clinics”).

December 31, 2019
·
1 min read